Metropolis Healthcare Allots 4,200 Equity Shares Under RSU Plan, Grants Stock Benefits to Employees

Metropolis Healthcare Limited's Nomination and Remuneration Committee convened on May 13, 2026, approving two significant employee benefit actions: the allotment of equity shares under its existing RSU plan and the grant of fresh stock benefits under its 2025 schemes. The meeting commenced at 09:00 a.m. (IST) and concluded at 12:10 p.m. (IST).

Allotment of Equity Shares Under MHL-RSU Plan, 2020

The committee approved the allotment of 4,200 equity shares against Restrictive Stock Units (RSUs) vested in and exercised by employees under the Metropolis – Restrictive Stock Unit Plan, 2020. The shares were issued at an exercise price of INR 2/- per share, with nil premium, aggregating to a total consideration of INR 8,400/-. The allotted shares rank pari-passu in all respects with the existing equity shares of the company.

The key details of the equity share allotment are summarised below:

Parameter:	Details
Date of Issue:	May 13, 2026
Number of Shares Issued:	4,200
Exercise Price per Share:	INR 2/-
Premium per Share:	Nil
Total Consideration:	INR 8,400/-
Distinctive Numbers:	20,73,27,769 to 20,73,31,968 (both inclusive)
Total Issued Shares After This Issue:	20,73,31,968
Total Issued Share Capital After This Issue:	INR 41,46,63,936/-
Lock-In Period:	1 year from date of allotment (50% of shares allotted to each RSU holder)
Date of Expiry of Lock-In:	May 13, 2027

The in-principle approvals for listing of these shares were received from BSE Limited vide letter no. DCS/ESOP/IP/RD/037/2026-27 dated April 23, 2026, and from the National Stock Exchange of India Limited vide letter no. NSE/LIST/54376 dated April 23, 2026.

Grant of Stock Benefits Under 2025 Schemes

In addition to the share allotment, the committee also approved the grant of stock benefits to eligible employees under two separate schemes introduced in 2025. These grants cover both RSU units and stock options, with structured vesting and exercise timelines.

The details of the stock benefit grants are as follows:

Parameter:	RSU Plan, 2025	ESOP Plan, 2025
Units/Options Granted:	14,236 units	2,12,345 options
Scheme Name:	Metropolis – Restrictive Stock Units Plan, 2025	Metropolis – Employees Stock Options Plan, 2025
Compliant with SEBI (SBEB) Regulations, 2021:	Yes	Yes
Total Shares Covered:	14,236	2,12,345
Exercise Price:	INR 2/- per unit (face value)	INR 375.62/- per option
Minimum Vesting Period:	1 year, extendable up to four years	1 year, extendable up to four years
Exercise Window:	Within 5 years from date of vesting	Within 5 years from date of vesting

Key Highlights

The allotted equity shares are issued under the MHL-RSU Plan, 2020, pursuant to RSUs vested and exercised by employees.
50% of the equity shares allotted to each RSU holder are subject to a lock-in period of one year from the date of allotment, expiring on May 13, 2027.
Fresh grants under the Metropolis – RSU Plan, 2025, and Metropolis – ESOP Plan, 2025, cover a combined total of 2,26,581 units and options for eligible employees.
Both 2025 schemes are compliant with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
The ESOP options under the 2025 plan carry an exercise price of INR 375.62/- per option, while RSU units are priced at face value of INR 2/- per unit.

The disclosures were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the requisite annexures have been submitted to the stock exchanges.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-2.19%	+4.60%	+14.38%	+7.34%	+31.02%	-9.35%

Metropolis Healthcare has notified the stock exchanges of a scheduled analyst and institutional investor meeting, pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, dated May 08, 2026, outlines the company's participation in an upcoming investor conference.

Investor Meeting Details

The meeting is scheduled to be held on May 27, 2026, as part of the 360 ONE Capital (B&K) Investor Conference. The following table summarises the key details of the interaction:

Parameter:	Details
Date:	May 27, 2026
Time:	10:00 a.m. (IST) onwards
Event:	360 ONE Capital (B&K) Investor Conference
Type of Interaction:	One to One & Group Meeting

Disclosure and Compliance

Metropolis Healthcare has confirmed that all discussions during the meeting will be based on publicly available information. The company has explicitly stated that no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction. The company has also noted that changes to the schedule may occur due to exigencies on the part of participants, the host, or the company itself.

The intimation has been filed by Kamlesh C Kulkarni, Head – Legal & Secretarial, and is available on the company's website at www.metropolisindia.com .